Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Cambrex sales rise in Q3 despite ‘challenging environment’

November 9, 2009 Manufacturing and Production, Research and Development CMO, CRO

Contract development and manufacturing services firm Cambrex saw its sales advance 2% to $58 million in the third quarter on …
News

Novartis gets German OK for swine flu vaccine

November 5, 2009 Research and Development, Sales and Marketing Novartis, h1n1

 Novartis’ swine flu vaccine Celtura has been approved in Germany, its first market, in what is a major milestone for …
News
Actelion Robin

Actelion UK appoints Robin Bhattacherjee General Manager

November 4, 2009 Research and Development, Sales and Marketing Actelion, appointment, research and development, sales and marketing

Actelion UK has appointed Robin Bhattacherjee general manager for the UK and Ireland. He will be based at the company’s …
Appointment

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …
News

Dr John Nash, Senior Director ADME/PK, BioFocus

November 3, 2009 Research and Development appointment, biofocus, research and development

BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK.  John has …
Appointment

Phase III success for GSK’s lupus drug

November 3, 2009 Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …
News

Whatever happened to yesterday’s ‘magic bullets’?

November 3, 2009 Research and Development Les Rose, biotech

How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …
Feature

Fast times at contract research firm PPD

November 3, 2009 Research and Development CRO

Pharmaceutical Product Development (PPD) has unveiled several new initiatives to re-inject some growth momentum into the business as its third-quarter …
News

GSK-Genmab blood cancer drug approved in US

November 2, 2009 Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …
News

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009 Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …
News

GSK begins phase III COPD trials

October 28, 2009 Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
News
Tarceva tablets

Comparing notes: UK’s cancer leaders discuss the latest advances

October 28, 2009 Research and Development, Sales and Marketing Cancer

 
Feature
Ipsen Claude

Claude Bertrand joins Ipsen as Chief Scientific Officer

October 27, 2009 Research and Development appointment, ipsen, research and development

Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …
Appointment

Quintiles will open new clinical unit in London next year

October 27, 2009 Research and Development NHS, Quintiles

Quintiles has agreed to set up a clinical research unit in London that will allow it to tap into the …
News

Consolidation wave likely to continue among European CROs

October 27, 2009 Research and Development cros

Another report concluding that the most successful contract research organisations (CROs) will be those that can offer a broad range …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026